United States · FDA National Drug Code directory
DILTIAZEM HYDROCHLORIDE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50228-499_2fc25445-56c7-4c39-ac18-32cc1023e7c2
- Product NDC
- 50228-499
- Form
- TABLET, EXTENDED RELEASE
- Composition / generic term
- diltiazem hydrochloride
- Labeler
- ScieGen Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230406
- Source listing expiry
- 20261231
Source-listed ingredients
- DILTIAZEM HYDROCHLORIDE — 360 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (50228-499-05) · 50228-499-05
- 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (50228-499-30) · 50228-499-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →